相关实验视频

Updated: Jun 30, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

用于癌症患者的全身抗癌疗法的血管接入装置类型:范围审查

C Duggan¹, O Hernon², R Dunne³

¹Department of Oncology, Portiuncula Hospital, Ballinasloe, Galway H53 T971, Ireland; School of Nursing and Midwifery, University of Galway, Ireland; Alliance for Vascular Access Teaching and Research (AVATAR) Group, Queensland, Australia.

Critical reviews in oncology/hematology

|March 16, 2024

概括

本综述强调了常见的血管接入装置 (VAD) 类型和癌症治疗的并发症. 需要进一步的研究和核心成果集,以改善患者的生活质量.

科学领域:

在瘤学瘤学.
医疗器械医疗器械
证据综合证据综合

背景情况:

癌症患者需要频繁的侵入性血管接入程序,用于化疗和诊断.
癌症发病率不断上升,需要更多地关注有效的静脉注射治疗输送方法.
优化血管接入装置 (VAD) 选择对于全身抗癌疗法 (SACT) 至关重要.

研究的目的:

系统地审查用于在癌症患者中提供全身抗癌疗法 (SACT) 的血管接入装置 (VAD) 类型的现有证据.
确定常见的VAD,相关并发症,地理趋势和对生活质量 (QOL) 的影响.
为未来的研究重点和临床实践指南提供信息,用于VAD在瘤学中的使用.

主要方法:

采用了JBI范围审查方法,对2012年至2022年间发表的英语文章制定了特定的搜索策略.
搜索了数据库,查找SACT交付,插入/插入后并发症,地理数据,临床环境和QOL影响的VAD类型的研究.
在选了5072个来源后,包括240篇文章,重点关注研究设计,VAD流行率,并发症率和QOL发现.

主要成果:

审查确定了240篇符合条件的文章,主要是回顾性研究设计. 道内静脉VAD和用于多种VAD类型的设备是最常见的.
与导管相关的血栓 (74%) 和感染 (71%) 是最常见的并发症. 中国是出版物的领先国家.
很少有研究涉及生活质量 (QOL),只有四项研究报告了身体形象. 通过VAD识别的SACT没有特定的QOL测量工具.

结论:

对SACT的VAD使用进行系统审查和元分析是可行的,但应优先考虑SACT的核心结果.
对癌症患者的VAD进行高质量的研究计划需要增加资金.
综合性癌症中心应该引领瘤学中VAD的研究议程,以改善患者的治疗结果和生活质量.

关键词:

抗癌药物抗癌药物抗癌药物中心静脉接入装置的使用方法化疗化疗是一种化学疗法.静脉内输入静脉内输入周围静脉静脉注射管道.系统性系统性系统性血管接入装置是一种血管接入装置.

更多相关视频

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.